ClinicalTrials.gg
CompletedNCT07934693Updated Nov 13, 2026

Effect of a Stress Ball on Stress and Anxiety in Mothers Having Their Infants Vaccinated

An interventional study of Stress Ball in Anxiety, Stress and Mother, sponsored by Gülistan Acaban. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Gülistan Acaban · Not applicable, Interventional, and Prevention

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

The purpose of this study is to examine the effect of stress ball use on stress and anxiety levels in mothers who visit a family health center to have their infants vaccinated. The study will address the following questions:

  • Does using a stress ball reduce mothers' stress levels?
  • Does using a stress ball reduce mothers' anxiety levels? The researchers will compare the stress ball intervention with the control group. Participants will be assigned to the intervention and control groups in a 1:1 ratio using a computer-generated random number list. Group assignments will be kept in sealed, numbered envelopes.

Participants will:

  • Be recruited from among mothers who visit Elazığ İzzetpaşa No. 1 Family Health Center to have their infants receive routine vaccinations and who meet the study's eligibility criteria.
  • Include approximately 72 mothers (36 in the intervention group and 36 in the control group).
  • Receive the stress ball intervention if assigned to the intervention group. The control group will receive the control procedure described in the study protocol.
  • Have their stress and anxiety levels assessed using the measurement instruments specified in the protocol.
Read the detailed description

The postpartum period is an important transition in a woman's life and may be associated with increased psychological stress and anxiety. Mothers who visit family health centers for their infants' routine vaccinations may experience anxiety and stress related to their infants' health, vaccination procedures, and concerns about potential adverse reactions. Providing simple, accessible, and non-pharmacological interventions to support maternal psychological well-being may therefore be beneficial in primary healthcare settings.

The purpose of this study is to evaluate the effect of stress ball use on perceived stress and anxiety levels among mothers attending Elazığ İzzetpaşa No. 1 Family Health Center for their infants' routine vaccination appointments.

This study is designed as a randomized controlled trial. A total of approximately 72 mothers who meet the eligibility criteria will be included in the study. Participants will be randomly assigned to either the intervention group or the control group in a 1:1 allocation ratio, with 36 participants planned for each group. Randomization will be performed using a computer-generated random number list. Allocation concealment will be ensured through sealed and sequentially numbered envelopes.

Mothers assigned to the intervention group will receive the stress ball intervention in addition to the routine procedures provided at the family health center. The stress ball will be used as a simple, non-pharmacological approach intended to help mothers manage psychological tension and anxiety. Participants will be instructed on how to use the stress ball during the intervention period.

Mothers assigned to the control group will receive the routine care and procedures provided at the family health center without the stress ball intervention.

The primary outcomes of the study are mothers' perceived stress levels and anxiety levels. These outcomes will be evaluated using the measurement instruments specified in the research protocol. Data will be collected at the time points defined in the study protocol to assess changes in stress and anxiety levels between the intervention and control groups.

The collected data will be analyzed statistically to compare the outcomes between the two groups and evaluate whether stress ball use has a beneficial effect on maternal stress and anxiety levels.

The findings of this study may provide evidence regarding the feasibility and potential effectiveness of a simple, low-cost, and non-pharmacological intervention for supporting maternal psychological well-being in primary healthcare settings. If beneficial effects are demonstrated, stress ball use may be considered as a supportive approach that can be incorporated into maternal care practices in family health centers.

02

Conditions studied

  • Anxiety
  • Stress
  • Mother
  • Randomized Controlled Trials

Browse trials for

03

In context

Anxiety Disorders Unverified

7,231 studies on the registry are indexed under Anxiety Disorders; 1,686 are open to participants now.

This study's enrollment of 72 is close to the median of 80 across 6,085 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

This is the only study on the registry with Gülistan Acaban as lead sponsor.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years and older
  • Mothers presenting to the Family Health Center for infant vaccination
  • Able to read and understand Turkish
  • Willing to participate in the study
  • Provided written

Exclusion criteria

Exclusion Criteria:

  • Having a diagnosed psychiatric disorder
  • Incomplete completion of study forms
  • Withdrawal from the study at any stage
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Stress Ball Intervention

    Participants assigned to the intervention group will receive a stress ball intervention in addition to routine care provided at the family health center. Before the intervention, participants will be informed about the purpose and proper use of the stress ball. They will be instructed to hold the stress ball in one hand and gently squeeze and release it repeatedly at a comfortable pace. Participants will be encouraged to breathe normally and focus on the squeezing and releasing movements during the exercise.

    Other: Stress Ball

  • No intervention
    No Intervention

    Routine education were provided.

Interventions

  • OtherStress Ball

    Mothers assigned to the intervention group were provided with a soft stress ball and instructed to squeeze it continuously during their infants' vaccination procedure at the Family Health Center. The intervention was administered only during the vaccination process and aimed to reduce maternal stress and anxiety associated with infant immunization.

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Inventory - State Anxiety Subscale (STAI Form TX-I)

    The State-Trait Anxiety Inventory - State Anxiety Subscale (STAI Form TX-I) is a 20-item self-report instrument used to assess participants' current levels of anxiety. Each item is rated on a four-point Likert scale ranging from 1 (Not at all) to 4 (Very much so). Ten positively worded items are reverse-scored. The total score ranges from 20 to 80, with higher scores indicating higher levels of state anxiety and lower scores indicating lower levels of state anxiety.

    Time frame: Maternal state anxiety assessed immediately before and immediately after infant vaccination procedure (Day 1, same study visit)

07

Study locations

1 site
  • Fırat University
    Elâzığ, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2026 to primary completion in Oct 2026, 2 months.

Of 3,859 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 2 months is below that.

Counting every sponsor, half of 3,962 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 13, 2026
StartActual
Aug 15, 2026
Primary completionActual
Oct 30, 2026
CompletionActual
Nov 6, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07934693
Lead sponsor
Gülistan Acaban
Responsible party
Gülistan Acaban (Midwife Gülistan Acaban, MSc, Firat University) — Sponsor-investigator
First posted
Nov 13, 2026
Start date
Aug 15, 2026
Primary completion
Oct 30, 2026
Completion
Nov 6, 2026
Last update
Nov 13, 2026

Study contacts

Serap ÖNER
principal investigator · Firat University
Gülistan Acaban
study director · Firat University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion